Pharmaceutical products

Image credit: Dyadic FB

Animal-Free Protein & Enzyme Producer Dyadic Applied BioSolutions to Receive Milestone Payments Following Commercial Progress

Global biotechnology company Dyadic Applied BioSolutions has announced the achievement of additional milestone payments in its collaborations with Proliant Health & Biologicals and Inzymes ApS. The company, which produces precision-engineered, animal-free proteins and enzymes for commercial applications, has also provided updates on its business transformation and commercial progress. In food and nutrition, Dyadic has announced the signing of a term sheet for the development of non-animal human alpha-lactalbumin for use …

more

Maia Farms receives funding from Genome BC Industry Innovation fund

© Maia Farms

Mycelium Ingredient Producer Maia Farms Receives $1.75M From Genome BC’s Industry Innovation Fund

Mushroom and mycelium ingredient company Maia Farms has received $1.75 million from Genome British Columbia’s Industry Innovation (I2) Fund. At its lab in Vancouver, Maia Farms upcycles agricultural byproducts to produce fermentation-based mushroom mycelium. The company’s clean-label ingredients can be used by manufacturers to add protein and fiber to a variety of products, from soups to ice cream. Maia Farms is also currently a partner on a Genome BC research …

more

Solar Foods mayo

© Solar Foods

Solar Foods Develops Mayonnaise Using Solein Protein as Egg Yolk Replacement

Solar Foods, a company specializing in microbial protein production, has created a mayonnaise product using Solein®, a protein derived from air, that replaces traditional egg yolk. This new formulation demonstrates the versatility of Solein, which can be used in a wide variety of food applications, including those that require protein sources like dairy or egg yolk. Solein, which is produced via fermentation, offers significant production advantages. When used in mayonnaise, …

more

© Onego Bio

Onego Bio Receives FDA “No Questions” Letter for Egg Protein Produced Through Precision Fermentation

Food ingredient company Onego Bio has received a “No Questions” letter from the US Food and Drug Administration (FDA) regarding Bioalbumen®, its egg protein produced through precision fermentation. The letter supports Onego Bio’s conclusion that Bioalbumen is Generally Recognized As Safe (GRAS) under its conditions of use in a wide range of food and beverage applications. This decision confirms that the ingredient can be used as a source of dietary …

more

Typcal

Image courtesy of biotope

Brazilian Mycoprotein Producer Typcal to Receive a €350K Investment Through Biotope Incubator

Typcal, a Brazilian startup growing mycoprotein using biomass fermentation, has been accepted into the seventh cohort of the biotech incubator biotopeby VIB. The company has reportedly developed proprietary fungi strains that grow faster and on more diverse feedstocks than competing technologies, enabling scalable, sustainable protein and fiber production. Through the program, Typcal will receive €250,000 in direct funding and €100,000 in non-cash tailored support, including mentoring and access to knowledge …

more

The Protein Brewery

© The Protein Brewery

The Protein Brewery Secures €30M to Advance Its Proprietary Mycoprotein

The Protein Brewery, a Dutch company producing fungi-based food ingredients, has secured €30 million in Series B funding. The round saw participation from new investors Invest-NL and the Brabant Development Agency (BOM), alongside existing investors Novo Holdings, Unovis Asset Management, and Madeli. The Protein Brewery will use the capital to advance its proprietary mycoprotein, Fermotein®, and strengthen its commercial presence. This will include expanding production capacity at the company’s Mijkenbroek …

more

SUMM Ingredients

© SUMM Ingredients

Nutrumami Rebrands to SUMM Ingredients and Secures €1.7M in Funding

Danish foodtech company Nutrumami has announced a rebrand to SUMM Ingredients. The new name reflects the company’s ambition to “sumup” multiple functions in one ingredient, along with delivering a greater sum of impact in terms of health, sustainability, and taste. SUMM Ingredients has also just raised €1.7 million in funding, with EIFO and BoxOne joining existing investors Kost Capital and Planetary Impact Ventures. The capital will be used to accelerate …

more

ÄIO produces first tonne of its yeast-based alternative to traditional oils

© ÄIO

Estonia’s ÄIO Produces First Tonne of Its Yeast-Based Alternative to Traditional Oils

Estonian biotech company ÄIO has completed the first full-scale production run of its yeast-based encapsulated oil product, reaching a volume of one tonne. This represents a 300-fold increase from the company’s laboratory capabilities. ÄIO uses biomass and precision fermentation to turn industrial side streams into non-animal fats and non-vegetable oils. The company’s encapsulated oil is said to be high in proteins, fibres, and functional lipids; it provides an environmentally friendly …

more

MilaK

© MilaK

Biotech Companies MilaK and iLoF Move Into Discovery Park’s CoLab in UK

Discovery Park in Kent has expanded its tenant portfolio with the addition of two early-stage biotechnology companies: MilaK, a precision fermentation protein startup, and iLoF, a digital health company working in the field of personalised drug development. Both firms have moved into new laboratory and office space at the park’s CoLab facility, a shared lab environment managed in partnership with Canterbury Christ Church University. Precision fermentation for nutrition applications MilaK, …

more

EdiMembre launches to produce edible membranes for alternative proteins

EdiMembre Co-Founders, Tim Olsen (left) and Ryan Sylvia (right). © EdiMembre

Merck and mantro Launch Spinoff Producing Edible Membranes for Cultivated Meat and Alt Protein Production

Science and technology company Merck has partnered with company builder mantro GmbH to launch EdiMembre, a deep-tech spinout that will commercialize Merck’s edible membrane technology for alternative proteins. The new company will expand the applications of the edible membrane platform, which enables the creation of complex tissue structures for scalable cultivated meat production and has also been used to explore high-protein plant-based pasta applications. Merck will not only contribute its …

more